Aluminum loading during total parenteral nutrition.

Area of Science:

• Clinical Nutrition
• Toxicology
• Bone Metabolism

Background:

• Long-term total parenteral nutrition (TPN) is a critical intervention for patients unable to receive nutrition orally.
• Concerns exist regarding the potential accumulation of aluminum (Al) from TPN solutions and its impact on patient health.
• Aluminum contamination in TPN has been linked to various adverse effects, including bone disease.

Purpose of the Study:

• To investigate the source of elevated aluminum (Al) levels in patients receiving long-term TPN.
• To determine the effect of substituting casein with amino acids in TPN solutions on Al levels.
• To assess the relationship between parenteral Al loading and tissue Al accumulation, especially in bone.

Main Methods:

• Patients on long-term TPN were assessed for aluminum (Al) levels in plasma and bone.
• The TPN solutions were analyzed to identify the source of Al.
• A dietary intervention involved substituting casein with amino acids in TPN, and subsequent changes in urinary and plasma Al were monitored.

Main Results:

• Elevated aluminum (Al) levels were detected in the bone and plasma of patients on long-term TPN.
• Casein, a component of the TPN solution, was identified as the source of Al.
• Substitution of casein with amino acids led to a significant decrease in urinary and plasma Al levels.

Conclusions:

• Parenteral administration of aluminum (Al) via TPN leads to increased tissue Al burden, notably in bone.
• The use of casein in TPN solutions is a likely contributor to aluminum accumulation.
• Prolonged use of casein-containing TPN solutions may pose risks and warrants careful consideration.